Name | TPX-0005 |
Synonyms | TPX-0005 Ropotrectinib 1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one,11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)- |
CAS | 1802220-02-5 |
Molecular Formula | C18H18FN5O2 |
Molar Mass | 355.3662232 |
Density | 1.46±0.1 g/cm3(Predicted) |
Solubility | DMSO: ≥ 83.3 mg/mL |
pKa | 10.79±0.60(Predicted) |
Storage Condition | -20℃ |
Physical and Chemical Properties | Bioactive Repotrectinib (TPX-0005) is a new type of ALK/ROS1/TRK inhibitor. The IC50 for WT ALK, ALK(G1202R) and ALK(L1196M) is 1.01 nM, 1.26 nM and 1.08 nM respectively. At the same time, it is also an effective SRC inhibitor, IC50 is 5.3 nM. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.814 ml | 14.07 ml | 28.14 ml |
5 mM | 0.563 ml | 2.814 ml | 5.628 ml |
10 mM | 0.281 ml | 1.407 ml | 2.814 ml |
5 mM | 0.056 ml | 0.281 ml | 0.563 ml |